Glasdegib
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for Glasdegib, covering 2017-11-06 to 2024-03-28. Get the full timeline:
Most recent: Clinical Trial Update: Glasdegib (PF-04449913) With Temozolomide Newly Diagnosed Glioblastoma [Phase 1, Phase 2]